REGISTERED NUMBER: 12444872 (England and Wales)

Unaudited Financial Statements for the Year Ended 28th February 2026

for

Jones Surgery Limited

Page

Balance Sheet

1

Notes to the Financial Statements

2

FIXED ASSETS

Tangible assets

4

3,872

2,693

CURRENT ASSETS

Debtors

5

3,739

2,654

Cash at bank

253,529

164,584

257,268

167,238

CREDITORS

Amounts falling due within one year

6

55,085

52,850

NET CURRENT ASSETS

202,183

114,388

TOTAL ASSETS LESS CURRENT LIABILITIES

206,055

117,081

PROVISIONS FOR LIABILITIES

736

512

NET ASSETS

205,319

116,569

CAPITAL AND RESERVES

Called up share capital

7

200

200

Retained earnings

205,119

116,369

SHAREHOLDERS' FUNDS

205,319

116,569

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28th February 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 28th February 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20th October 2026 and were signed on its behalf by:

Dr R P Jones - Director

1.	COMPANY INFORMATION

Jones Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

12444872

Registered office:

The Lexicon

Mount Street

Manchester

M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation,

net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values

over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset and is credited or charged to the profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

fittings

£

COST

At 1st March 2025

5,233

Additions

2,446

At 28th February 2026

7,679

DEPRECIATION

At 1st March 2025

2,540

Charge for year

1,267

At 28th February 2026

3,807

NET BOOK VALUE

At 28th February 2026

3,872

At 28th February 2025

2,693

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

28.2.26

28.2.25

£

£

Trade debtors

3,739

2,654

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

28.2.26

28.2.25

£

£

Tax

50,348

44,650

VAT

1,551

4,882

Directors' current accounts

23

311

Accrued expenses

3,163

3,007

55,085

52,850

7.	CALLED UP SHARE CAPITAL

Allotted and issued:

Number:

Class:

Nominal

28.2.26

28.2.25

value:

£

£

100

Ordinary A

1

100

100

100

Ordinary B

1

100

100

200

200

The A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The B Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B Shares rank pari passu in respect of dividend and capital distribution rights.

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28th February 2026 and 28th February 2025:

28.2.26

28.2.25

£

£

Dr R P Jones

Balance outstanding at start of year

(311

)

(171

)

Amounts advanced

66,620

103,172

Amounts repaid

(66,333

)

(103,312

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(24

)

(311

)

The loan is repayable on demand and no interest was charged during the year.

9.	ULTIMATE CONTROLLING PARTY

The controlling party is Dr R P Jones.